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Summary 
 
The stemness state is characterized by self-renewal and differentiation properties. 
However, stem cells are not able to preserve these characteristics in long-term culture 
because of the intrinsic fragility of their phenotype easily undergoing senescence or 
neoplastic transformation. Furthermore, although isolated from the same original tissue 
using similar protocols, adult stem cells can display dissimilar phenotypes and important 
cell clone/species contamination. Finally, the lack of a clear standardization contributes to 
complicate the comprehension about the stemness condition. In this context, cell lines 
displaying a particularly stable phenotype must be identified in order to define one or 
multiple benchmarks against which other stem cell lines could be reliably assessed. The 
present paper demonstrates that it is possible to isolate from the rat dental pulp a stem cell 
line (MUR-1) that does not display neoplastic transformation in long-term culture. MUR-1 
cells stably express a broad range of stemness markers and are able to differentiate into 
adipogenic, osteogenic, chondrogenic, neurogenic and cardiomyogenic lineages 
independently of the culture passages. Moreover, serial in vitro passages have not 
changed their immunophenotype, proliferation capacity or differentiation potential. The 
uniqueness of these characteristics candidates MUR-1 as a model to reliably improve the 
understanding of the mechanisms governing the stem cell fate in the same as well as in 
other stem cell populations. 
Introduction 
The interest around stem cells has increased over the years proportionally to new findings. 
Although postulated about one century ago [1], stem cells were revealed only in the 1963 
[2]. The discovery of “cluster of hæmatopoietic cells” within the bone marrow paved the 
way to the first stem cells transplant [3] starting the regenerative medicine era. 
In the last decade, stem cells have been identified in almost all body tissues [4], from 
which they have been isolated on the basis of their intrinsic characteristics of self-renewal 
and potency. Among others, adult mesenchymal stem cells (MSC) have attracted great 
attention for their ability to generate different cell lineages [5-7], fueling the assumption that 
they could be the panacea to regenerate all injured tissues. Nevertheless, the clinical 
worthiness of MSC to repair injured organs remains a chimera. In fact, owing to the poor 
knowledge of some MSC intrinsic features together with the inadequacy of current 
handling and engraftment protocols, clinically reliable cell treatments are still lacking.  
In mammals, MSC are segregated in particular tiny regions (niches) in which the 
microenvironment governs their quiescence, self-renewal and/or commitment [8]. Each 
niche is thus responsible for MSC features and behavior in terms of growth and 
differentiation potential. In bone marrow, MSC represent only a small percentage (0.5-10% 
depending on the anatomical site) of the total cell population [8-10] and are often hardly 
identifiable for their morphological and biochemical camouflage with the differentiated 
surroundings [8,11]. Moreover, even if correctly isolated, MSC are not able to retain their 
stemness condition when cultured in vitro for long-term [12], very likely because of the lack 
of niche control. Consistently, stem cell primary cultures undergo senescence and their 
capabilities of self-renewal and multi-potency are faded by an innate drift towards 
commitment linked to in vitro conditions [13,14]. On the other hand, MSC, when apparently 
not affected by senescence after prolonged in vitro culture, may acquire cytogenetic 
abnormalities prompting unwanted neoplastic transformations [15].  
Furthermore, although isolated from the same tissue following identical protocols, primary 
MSC cultures can display dissimilar phenotypes, corresponding to different stages of cell 
immaturity along the differentiation pathway [16-18] and/or important contamination 
problems [13,19-24]. Consistently, similarly to the Hindu “Blind men and an elephant” tale 
[25], different investigators have described the same stem cell population using a plethora 
of often non-specific “Cluster of Differentiations” markers. As result, the lack of 
standardized procedures in stem cell research [26] confuses and complicates the 
comprehension about the stemness condition, consequently frustrating the regenerative 
medicine philosophy itself. On these evidences, it is of paramount importance to identify 
populations that can be used as benchmarks to validate further advancements in stem cell 
research. In this context, the aim of the present study has been to verify the phenotypic 
stability in long-term culture and the capability to differentiate upon specific stimuli of a 
stem cell population (MUR-1, from latin Mòrsus/Múrsus = muzzle) isolated from the dental 
pulp of rat continuously growing incisors. Indeed, the results have shown that MUR-1 are 
adult mesenchymal stem cells characterized by geno/phenotypical stability and non-
tumorigenicity in long-term culture. These characteristics candidate them as a benchmark 
in stemness/differentiation studies as well as to assess the potency of other stem cell 
populations.  
 
Materials and Methods 
Cell Isolation and Purification 
Dental pulp stem cells (DPSC) were isolated from mandible incisive teeth of five months 
old male Wistar rats (Charles River, Monza, Italy). The dental pulp was gently removed 
through the apical foramen. The resulting tissue was washed twice in phosphate buffered 
saline (PBS) and centrifuged for 5 min at 1000 rpm; subsequently, the dental pulp was 
digested, washed, and seeded as previously described [27]. After 24 h, non-adherent cells 
were removed while the remaining cells were cultured in RPMI-1640 supplemented with 
10% fetal calf serum (FCS), 100 U/ml penicillin G, 40 μg/ml gentamicin sulfate and 2.5 
μg/ml amphotericin B (all from Sigma-Aldrich, St Louis, MO, USA) at 37°C in a humidified 
5% CO2 atmosphere. The final clone selection was conducted by serial dilutions in 96-well 
plates. Only wells enclosing homogeneous population were considered for further 
expansion. Among them, one clone (named MUR-1) was chosen for subsequent 
experimentations.  
 
MUR-1 Culture Conditions and Cryopreservation 
Cells were cultured in 75 cm2 TPP® flasks (TPP AG, Switzerland) as above described, 
without any feeder-layer. Cells were harvested twice a week with 0.25% trypsin solution 
(Sigma-Aldrich). Standard 1:4 dilution ratio was used for cell expansion while MUR-1 
cryopreservation was performed in the same culture medium added of 10% DMSO. 
 
FACS Analysis, Cell Growth Kinetics, and Colony-Forming Units Fibroblastoid Assay 
Cell volume and morphological complexity was assessed by a FACScalibur (Beckton 
Dickinson Italia SpA, Buccinasco, Italy) instrument, after suspension at the density of 
5x105 cells/ml. Doubling time (DT) of cell line was calculated as previously described [28] 
in cells (1x105) seeded into 25 cm2 flasks and cultured in complete medium. The 
clonogenicity of DPSC was determined by means of the Colony-Forming Units 
Fibroblastoid (CFU-F). Cells were seeded in 25 cm2 flasks at the density of 2, 5, or 10 
cells/cm2. After two weeks, the adherent cells were toluidine blue-stained, and 
macroscopic colonies were counted. All experiments were performed in triplicate. 
 
Light and Electron Microscopy 
MUR-1 cell morphology in adherent conditions was investigated in cells cultured on 
coverslips (DelChimica, Napoli, Italy), stained with haematoxylin/eosin, and observed by 
light microscopy. For electron microscopy, cells were processed as previously described 
[29]. 
 
Karyotype Analysis  
Chromosome analysis was performed every 6 months of culture adopting a conventional 
G-banding karyotype protocol. Briefly, cells undergoing active division were blocked at 
metaphase by colchicine and actinomycin D, detached from the growth surface by trypsin–
EDTA, and subsequently swollen by exposure to hypotonic KCl solution. Cells were then 
fixed in methanol/acetic acid solution, glass-mounted and finally metaphase dishes were 
identified by light microscope and photographed. Chromosomes were identified according 
to the Committee for a Standardized Karyotype of Rattus norvegicus [30]. 
 
mRNA and Protein Expression Analysis 
Total RNA was extracted with TRIreagent solution (Sigma-Aldrich) according to 
manufacturer’s instructions. One microgram of RNA was purified from contaminating DNA 
through a Deoxyribonuclease I kit and retrotranscribed with Random Hexamer Primer 
according to M-MuLV Reverse Transcriptase manufacturer’s instructions (all reagents 
were from Fermentas International Inc., Burlington, Canada). PCR reactions were carried 
out using 2.5 μl cDNA, 2.5 μl 10X PCR Buffer II (Roche Applied Science, Indianapolis, 
USA), 1.5 μl 25 mM MgCl2, 0.5 μl 10 mM dNTP (Fermentas), 0.75 μl of each specific 10 
μM primer (Sigma-Genosys), and 0.05 U/μl Taq DNA Polymerase (Fermentas) to a final 
volume of 25 μl. Specific primer sequences are summarized in Table 1. Amplification 
products were separated by agarose gel electrophoresis. DNA bands were stained with 
ethidium bromide and digitally captured by Kodak ImageStation. As positive controls, 
cDNAs extracted from brain (for Thy1, cKit, Oct4, Stella, SSEA1, Tubb3, and Sox2), foetal 
brain (MEF2C), heart (GATA4, ACTC1, CX43, and ADRB1), pancreas (Islet1), lung 
(ADRB2, Fragilis1, ALPL, and HLA-DR), and liver (HDAC6) were used. 
Protein expression was assessed by immunocytochemistry analysis. MUR-1 cells were 
cultured on poly-D-lysine-coated coverslips and then incubated with specific primary 
antibodies overnight at 4°C and then with appropriate secondary antibodies for 1 h at room 
temperature. Primary antibodies are reported in Table 2. Image acquisition of CD90, 
CD117, YAP1, vimentin, Nkx2.5, CD45, and CD34 expression was carried out with a LSM 
510 confocal laser microscopy system (Zeiss, Jena, Germany), while FLK1, alpha smooth 
muscle actin (αSMA), cMyc, CD105, and GATA-4 expression was visualized under a Leica 
DRMB microscope equipped with a digital camera. 
 
Differentiation Culture Conditions 
The adipogenic differentiation was induced by growing MUR-1 cells in RPMI-1640 
containing 10% FBS, 1.7 μM insulin, 1 μM dexamethasone, and 0.5 mM 
methylisobutylxanthine (Sigma-Aldrich) [31]. After 5 days of induction, cells were fixed with 
4% paraformaldehyde for 20 min, washed with PBS, incubated with Nile Red (Sigma-
Aldrich) for 10 min to emphasize lipid vesicles occurrence [32] and then observed by 
confocal laser microscope. For electron microscopy, differentiated cells were processed as 
previously described [29].  
Osteogenic differentiation was induced in MUR-1 cells cultured in complete medium 
supplemented with 10 mM β-glycerophosphate, 0.05 mM ascorbic acid, and 100 nM 
dexamethasone [33]. After 3 weeks, osteogenic differentiation was evaluated by alkaline 
phosphatase staining kit (BioOptica Milano SpA, Milano, Italy).  
MUR-1 chondrogenic differentiation was induced by complete medium supplemented with 
10 ng/ml TGF-β3, 0.025 mM ascorbic acid, and 100 nM dexamethasone [34]. After 3 
weeks, differentiated cells were highlighted with toluidine blue staining as described 
elsewhere [35].  
MUR-1 neuro-glial differentiation was induced by pre-treating cells with 1 mM β-
mercaptoethanol in complete medium for 24 h and then with 35 ng/ml retinoic acid for 72 
h. Subsequently, MUR-1 cells were grown in complete medium supplemented with 5 ng/ml 
PDGF (Platelet-derived Growth Factor), 10 ng/ml bFGF (basic Fibroblast Growth Factor), 
252 ng/ml GGF (Glial Growth Factor), and 14 μM Forskolin for 2 weeks [36]. The induction 
of neuro-glial phenotype was confirmed by specific immunostaining for neuron growth-
associated protein 43 (GAP43 - Goat, 1:100, Santa Cruz Biotechnology, Santa Cruz, CA, 
USA), glial fibrillary acidic protein (GFAP - Mouse, 1:50, DakoCytomation, Dako Italia SpA, 
Milano, Italy) and S100 protein (Rabbit, 1:400, Sigma-Aldrich). MUR-1 cells without 
differentiation factors were prepared in the same conditions and used as negative controls. 
Myocardial differentiation was induced through direct co-culture of MUR-1 with murine 
neonatal cardiomyocytes in complete medium for 7 days. Neonatal cardiomyocytes were 
obtained as described elsewhere [37] and plated at the concentration of 5x104 cells/cm2 
onto fibronectin (2 μg/ml)-laminin (0.2%) pre-coated glass chamber slides (BD 
Biosciences, San Jose, CA). Twenty-four hours later, MUR-1 cells, previously labeled with 
1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine perchlorate (DiI, Vybrant™, 
Molecular Probes, Life Technologies Italia, Monza, Italy), were seeded onto 
cardiomyocytes at a 1:5 ratio. MUR-1 without cardiac cells and viceversa were prepared in 
the same conditions and used as controls. The induction of myocardial differentiation was 
assessed by evaluating sarcomeric α-actinin (Mouse, 1:700, Sigma-Aldrich), connexin 43 
(CX43) (Rabbit, 1:100, Sigma-Aldrich) and Troponin I (Rabbit, 1:50, Santa Cruz 
Biotechnology) expression.  
 
Colony Formation and Tumorigenicity Assay 
Soft-agar assay was carried out to evaluate the possibility that MUR-1 cells could undergo 
anchorage-independent growth. Briefly, 1x105 MUR-1 cells were seeded into 10 mm Petri 
dish in 0.3% agar-complete medium. Cells were cultured for 21 days and then colony 
formation assessed by means of light microscopy. MUR-1 tumorigenicity was evaluated in 
vivo by injecting 1.0 or 10x106 cells between the shoulder blades in six male Wistar rats 
randomly divided into two groups. Animals were followed for 60 days, evaluating whether 
masses were developing in the injection area. At 10, 30 and 60 days, one rat for each 
group was anesthetized and sacrificed. Tissues surrounding the injection area were 
excised and processed for histological analysis by standard haematoxylin/eosin stain. The 
whole experimentation was performed according to the Ethic Committee of the University 
of Turin, Italy. 
 
Statistical Analysis 
DT and CFU-F were expressed as arithmetical mean ± standard deviation. DT results 
were analyzed with a two-tailed paired t-test, whereas one-way ANOVA and Newman-
Keuls Multiple Comparison Test (for post-ANOVA comparisons) were used to evaluate the 
statistical significance of the CFU-F differences. All analyses were carried out with 
GraphPad Prism version 5.00 (GraphPad Software, San Diego, CA, USA, 
www.graphpad.com), with P < 0.05 as the significance cut-off. 
Results 
 
CFU-F, Growth Kinetic, Karyotype and Morphological Characteristics 
Under light microscopy (Fig. 1A), adherent MUR-1 cells showed a fibroblastoid shape; 
after haematoxylin/eosin staining (Fig. 1B), they displayed an irregular and eosinophilic 
cytoplasm with central round nucleus. Electron microscopy revealed a pale, eccentric and 
irregularly shaped nucleus with one or more nucleoli located near the MUR-1 perinuclear 
cisternae (Fig. 1C,D). Chromatin was spread throughout the nucleus except for a thin 
dense layer located immediately inside the perinuclear cisternae (Fig. 1D,E). The 
cytoplasm was rich in mitochondria and ribosomes predominantly associated with 
endoplasmic reticulum (Fig. 1F,G). Yet, ultrastructural observation showed that the 
irregularities of the plasma membrane seen by light microscopy were due to small 
pseudopodia located all around the cells (Fig. 1C,H). 
MUR-1 cells were characterized by an estimated doubling time of 25.4±2.2 and 23.2±1.8 h 
at the exponential growth phase, when assessed after thirty (P30) and two-hundred (P200) 
culturing passages, respectively (P30 vs. P200, P=0.120). The frequency of CFU-F was 
proportional to the cell seeding density (P=0.0028 and P=0.001 at P30 and P200, 
respectively). The CFU-F corresponding to 2, 5, and 10 cells/cm2 was 73.7±14.4, 
179.7±23.7, and 250.0±55.9 for MUR-1 at P30, and 77.0±10.5, 147.3±26.8, and 
256.7±43.8 for MUR-1 at P200, respectively (Fig. 2A). Results did not show any significant 
differences in terms of CFU-F between P30 and P200 passages. As evinced by FACS 
analysis, MUR-1 was a population with homogeneous dimensions and morphological 
complexity (Fig. 2B). During the entire cell culture time, G-banding cytogenetic analysis of 
MUR-1 cells did not reveal macroscopic chromosome alterations, if compared with the 
reference rat karyotype (Fig. 2C). In addition, cryopreservation did not affect MUR-1 
characteristics, in accord to what already described [38]. 
 
 
MUR-1 Gene and Protein Expression  
Analysis of mRNA expression (Fig. 3) revealed that MUR-1 cells transcribed several genes 
related to the embryonic/pluripotent undifferentiated status, as the transcription factor 
OCT4 (POU5F1), the membrane glycoprotein Thy-1 (CD90), the tyrosine-kinase receptor 
c-Kit (CD117), the developmental pluripotency-associated protein 3 (Stella), the stage-
specific embryonic antigen 1 (SSEA1), the interferon-induced transmembrane protein 1 
(Fragilis 1), and the hystone deacetylase 6 (HDAC6), but not the SRY-box2 transcription 
factor (SOX2). Contextually, commitment transcripts were present: MUR-1 cells expressed 
mRNAs encoding for the transcription factors GATA4 and MEF2C, as well as the 
cytoskeleton components ACTC1 and tubulin β3, the gap-junction CX43, and the receptor 
ADRB2, but they did not transcribe those for the ISL-1 transcription factor (islet-1), ADRB1 
receptor, the non tissue specific alkaline phosphatase (ALPL), and the major 
histocompatibility complex HLA-DR.  
At the protein level (Fig. 4), the expression of stem cell antigens CD90 and CD117 was 
further confirmed. Consistently, the presence of c-MYC transcription factor, TGFβRIII 
receptor Endoglin (CD105), FLK1 receptor (VEGFR2 or CD309), CX43, important 
transcription factors (NKX2.5, GATA4, and YAP1), intermediate filament vimentin, and α 
smooth muscle actin (αSMA) was highlighted. MUR-1 cells did not express typical blood 
lineage commitment markers, namely CD34 and CD45.  
 
Plasticity of MUR-1 Cells  
Adequately treated MUR-1 cells have been able to successfully differentiate in precursors 
of different histotypes, also after prolonged culture (P200). Following adipogenic stimuli, 
the presence of lipid-rich cells was detectable with the lipophilic Nile Red dye (Fig. 5A): 
indeed, ultrastructural observation indicated the presence of lipid droplets inside the cells 
(Fig. 5B). If compared with untreated MUR-1 cells (Fig. 5C), chondrogenic medium led to 
the formation of round-shaped cell clusters characterized by a basophilic cytoplasm (Fig. 
5D). Similarly, osteogenic stimulation induced the aggregation of clusters of alkaline 
phosphatase-stained round-shaped cells surrounded by a dense extracellular matrix (Fig. 
5E,F).  
MUR-1 cells were also able to trans-differentiate into other cell types. If cultured with 
appropriate growth factors (see Materials and Methods section), MUR-1 may acquire 
neuronal morphologies including bipolar one (Fig. 5G), and express neuro-glial markers, 
such as GAP43 (Fig. 5H), GFAP (Fig. 5I), and S100 (Fig. 5J), within 2 weeks of 
incubation.  
The co-culture of MUR-1 with neonatal cardiomyocytes induced cardiac differentiation as 
demonstrated by the expression of troponin I (Fig. 5K,L), CX43 (Fig. 5M,N) and α 
sarcomeric actinin (Fig. 5O,P), assembled in sarcomeric bands within the cells.  
 
Soft-Agar and Isograft Assay  
After more than 6 months of continued culture, MUR-1 cells were assessed for their 
tumorigenic potential. Both in vitro and in vivo tests showed no cells colony and mass 
development in the soft-agar test and in subcutaneously injected tissues, respectively. 
Also autoptic analysis of isograft areas of injection did not reveal the presence of any 
inflammatory infiltrates (data not shown).  
 
Discussion 
 
Dental pulp holds promise to be an interesting source of different adult stem cell 
populations generally characterized by an enhanced differentiation potential [39-41], 
although the gene/antigen expression profile is comparable to bone marrow stem cells 
[27]. Nevertheless, the actual potential of DPSC has been underestimated, since 
investigations have predominantly been focused on obtaining cells for in vivo 
dental/calcifying tissue recovery. 
The present study demonstrates that, among DPSC, it is possible to isolate a cell line 
(MUR-1) displaying uncommon properties and behavior, even thought morphological 
features strictly resemble those of MSC [27]. Ultrastructural analysis of MUR-1 cells 
reveals a finely dispersed euchromatin, presence of numerous mitochondria featuring 
tightly pleated cristae, and several ribosomes associated to the endoplasmic reticulum, 
clues of easy access to transcription factors, enhanced energy production and protein 
synthesis, respectively. Furthermore, MUR-1 cells transcribe and translate the classical 
CD90+/CD117+/CD34-/CD45- profile without commitment to blood lineages, typically 
depicting the undifferentiated mesenchymal condition [7]. This expression pattern 
associates with that of both c-Myc and Oct4, which are essential to induce self-renewal in 
embryonic stem cells and are pivotal to sustain pluripotency [42]. Intriguingly, MUR-1 cells 
also express Stella antigen, further clue of self-renewal and multi/pluripotency. In fact, 
Stella has been observed, up to now, only in the embryo inner mass cells and in the germ 
cells line [43], where it acts as protector of the DNA demethylation, as demonstrated by its 
involvement in epigenetic reprogramming [44]. In addition, MUR-1 cells express the 
embryonic SSEA1 marker, which is also specific for neural crest cells [45,46], and Fragilis 
1, which is mainly present in the mesoderm and the pharyngeal arch during the embryo 
development [47]. Finally, the expression of YAP1, marker of epithelium-mesenchyma 
transition [48], could represent the remnant of the ecto-mesenchymalization process 
underlying the dental pulp development. Indeed, the dental pulp originates from an unique 
mesenchyma-epithelium cross-talk, in which the epithelium of the first pharyngeal arch 
interacts with the neural crest, considered as the mesenchymal counterpart [49-51].  
These evidences indicate that MUR-1 are characterized by a very early differentiation 
status, as also confirmed by their high proliferation rate and clonogenic potential. Notably, 
both phenomena remain unchanged up to the 200th culture passage.  Since cells cultured 
in vitro for extended periods could escape senescence when affected by genetic 
aberrations and neoplastic transformation, MUR-1 cells have been repeatedly karyotyped 
without any evidence of macroscopic chromosomal alterations.  Furthermore, they were 
neither able to grow in vitro without adhesion-support nor to provoke mass development 
after injection in living experimental animals. Taken together, these evidences indicate that 
long-term cultured MUR-1 cells cannot be considered cancerous. 
Beside these characteristics, MUR-1 cells translate both CD105 and Flk1 antigens 
strengthening the mesenchymal feature, though they are also typical endothelial markers 
[52,53]. Notably, albeit being negative for ADRB1, MUR-1 cells display a cardiac/vascular-
like CD117+/Flk1+/NKX-2.5+/MEF2C+ profile, together with the low expression of endoderm 
gene GATA4. Such a pattern concurs to postulate a parenting with those cells driving the 
cardiogenesis during the embryo development [54,55]. In addition, CX43 is functionally 
organized in cell membranes, likewise the high motility neural crest cell subpopulation that 
arises in the endothelium of the aortic arch arteries and the septum between the aorta and 
the pulmonary artery [56], and portions of the cardiac conduction system [57]. These data 
suggest that MUR-1 cells could share a neural crest ancestral progenitor, while prone to 
differentiate to cardiomyocytes. Additionally, MUR-1 cells express ADRB2 that is involved 
in both adipo- and osteogenic differentiation [58,59], and vimentin, a marker of early neural 
phenotype [60], but also generally related to the mesenchymal status [61]. Finally, markers 
of differentiations, such as non-tissue-specific alkaline phosphatase or HLA-DR, have not 
been detected.  
This broad profile of MUR-1 gene and antigen expression is reflected by their potency. 
Indeed, MUR-1 cells are able to adopt an adipocyte, chondrocyte and osteocyte  
phenotype, as evinced by the intracellular lipid vesicles development, the basophilic 
cytoplasm and alkaline phosphatase activity, respectively. These capabilities are 
substantially equivalent to those of stem cells from bone marrow. Furthermore, besides the 
above mentioned differentiating capabilities, MUR-1 cells can generate neuronal and glial 
precursors expressing typical markers, such as GFAP, GAP43 and S100, which are 
involved in neurite formation and elongation [62,63]. Finally, they can differentiate to 
cardiomyocytes expressing troponin I and α sarcomeric actinin in properly assembled Z-
disks; conversely, CX43 expression and location remain as in undifferentiated MUR-1 
cells. Notably, the MUR-1 extended differentiating potential remains unchanged 
independently of the cell passage and is not significantly affected by supplement/feeder-
layer free culture conditions, such as when they are cultured in low-antioxidant high-
glucose RPMI-1640. This is a very peculiar feature of MUR-1 cells, since the increment of 
the Reactive Oxygen Species (ROS) level within stem cells is believed to be inversely 
correlated with the maintenance of their stemness state [64].  
It can be speculated that MUR-1 peculiar characteristics could be related to the continuous 
growth of Myomorpha teeth during the entire animal life; however, adult stem cells deriving 
from other continuously growing tissues do not display a similar behavior. For example, 
when bone marrow-MSC are cultured in vitro, they lose the capability to self renew within 
30-50 population-doublings [65,66]. 
All these observations indicate that the MUR-1 cells phenotype can be properly maintained 
even after isolation from their native niches. This is in apparent contrast with the notion 
that niche is crucial in regulating stem cells proliferation, self-renewal and differentiation 
potential [67]. It can be conjectured that, under some respect, culture conditions mimic the 
native niche environment. 
In conclusion, MUR-1 is a cell population phenotypically very stable in conventional culture 
conditions and, at the same time, endowed with a very extensive differentiating potential 
that can be easily activated with specific stimuli. This makes MUR-1 a very reliable model 
to study the mechanisms regulating stemness state and to test biologically active 
substances of potential pharmacological interest. Furthermore, MUR-1 could represent a 
benchmark to assess the characteristics and potential of many other stem cell populations, 
whose phenotypic instability has so far hampered to deepen the knowledge about their 
behavior. 
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